MAXHEALTH1,033.10

Max Healthcare Institute Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPFORTISMEDANTADRREDDYCIPLASUNPHARMADIVISLABTORNTPHARMMcap ₹1.01L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations5,406.07,028.58,373.58,712.1
Other Income178.1155.6162.6166.6
Total Income5,584.17,184.18,536.18,878.7
Expenses
+ Purchases of Stock-in-Trade1,119.01,496.41,798.81,866.1
+ Changes in Inventories-0.5-19.4-8.7-7.9
+ Employee Benefit Expense934.41,174.01,357.11,407.2
+ Finance Costs59.9165.0235.1251.3
+ Depreciation & Amortisation245.0359.4446.5474.1
+ Other Expenses1,861.02,528.62,983.53,128.3
Total Expenses4,218.85,704.16,812.37,119.0
EBITDA1,492.11,848.82,242.82,318.4
EBIT1,247.11,489.41,796.31,844.3
Profit
PBT before Exceptional Items1,365.31,480.01,723.81,759.7
+ Exceptional Items0.0-73.6-48.2-48.2
Pretax Income1,365.31,406.41,675.61,711.5
+ Current Tax271.3336.1211.3197.3
+ Deferred Tax36.4-5.621.956.7
Tax Expense307.7330.5233.2254.1
Net Income1,057.61,075.91,442.41,457.4
+ Net Income — Continuing Ops1,057.61,075.91,442.41,457.4
+ Other Comprehensive Income-6.5-4.6-1.6-3.6
Total Comprehensive Income1,051.21,071.31,440.81,453.8
Net Income to Common1,051.2
Per Share
Basic EPS10.8911.0714.8314.99
Diluted EPS10.8411.0114.7614.91
Other Comprehensive Income — detail
+ Other Comprehensive Income-4.6-1.6-3.6
+ Items NOT to be Reclassified to P&L-6.8-5.1-1.81.7
+ Tax on Items NOT to be Reclassified-0.80.00.8
+ Tax on Items NOT to be Reclassified — alt tag-0.8
+ Items to be Reclassified to P&L-0.5-0.30.3-6.2
+ Tax on Items to be Reclassified0.00.0-1.6
Per Share — as-filed variants
Basic EPS — Continuing Operations10.8911.0714.8314.99
Diluted EPS — Continuing Operations10.8411.0114.7614.91
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit4,287.55,551.46,583.46,853.9
Gross Margin %79.3178.9878.6278.67
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)1,365.31,480.01,723.81,759.7
− Exceptional Items (reconciliation)0.0-73.6-48.2-48.2
Net Income Adj (tax-effected)1,057.61,132.21,483.91,498.5
EPS Adj10.8911.6515.2615.41
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital971.9972.1973.1973.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.